Literature DB >> 35870043

Denileukin diftitox-induced systemic capillary leak syndrome with acute kidney injury.

Taro Horino1, Daiki Okada2, Satoshi Inotani2, Hideki Nakajima3, Masahiro Komori4, Yoshio Terada2.   

Abstract

Systemic capillary leak syndrome is a rare and life-threatening disorder, characterized by recurrent episodes of unexplained hypotension, hemoconcentration, and hypoalbuminemia. This condition is caused by leakage of plasma and proteins into the extravascular space and can be classified as either idiopathic or secondary. Secondary systemic capillary leak syndrome can result from cancer, infections, medications, or surgery. Systemic capillary leak syndrome frequently develops as a side effect of denileukin diftitox treatment of refractory cutaneous T-cell lymphoma. However, the pathophysiology of this disease is not well understood. Herein, we report a case of denileukin diftitox-induced systemic capillary leak syndrome.
© 2022. The Author(s) under exclusive licence to The Japan Society of Nephrology.

Entities:  

Keywords:  99mTc-HSA scintigraphy; Acute kidney injury; Cutaneous T-cell lymphoma; Denileukin diftitox; Interleukin-2 receptors; Systemic capillary leak syndrome

Year:  2022        PMID: 35870043     DOI: 10.1007/s13730-022-00720-3

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  1 in total

1.  New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan.

Authors:  Naoki Nakagawa; Shoichi Maruyama; Naoki Kashihara; Ichiei Narita; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2022-05-15       Impact factor: 2.617

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.